MDL Judge Reinstates Taxotere Hair Loss Plaintiff’s Claims Against Hospira
May 2, 2022
DOCUMENTS
- Order
NEW ORLEANS — A Louisiana federal judge has granted a Taxotere hair loss plaintiff’s motion to reinstate her claims against Hospira Worldwide LLC and Hospira Inc. based upon evidence that they manufactured the chemotherapy drug she received during treatment.
In an April 29 order, Judge Jane Milazzo of the U.S. District Court for the Eastern District of Louisiana found the plaintiff met her burden under Federal Rule of Civil Procedure 60(b) for vacatur of her notice of voluntary dismissal.
Plaintiffs in the MDL are suing several drug companies that manufactured and/or distributed Taxotere (docetaxel), alleging the drug caused permanent alopecia. …
UPCOMING CONFERENCES
HarrisMartin's New Jersey Asbestos Litigation Conference
February 27, 2025 - New Brunswick, NJ
Hyatt Regency New Brunswick
HarrisMartin’s Artificial Stone Silicosis Epidemic Litigation Conference
January 10, 2025 - Long Beach, CA
The Westin Long Beach